We observed that high LINC00052 expression is associated with increased survival in patients with luminal A, ER+, PR+ and TNBC breast cancer, data consistent with previous reports that showed that high LINC00052 expression is associated with greater overall survival in BC patients [15,20]. The gene discussed is PGR; the disease is breast carcinoma.